ASCO 2024: Advances in Melanoma and Related Cancers

CEDARS-SINAI THE ANGELES CLINIC AND RESEARCH INSTITUTE - WEST LOS ANGELES
In collaboration with the AiM at Melanoma Foundation, we are excited to share this post-ASCO webinar event. Dr. Omid Hamid, MD, the Chief of Research in Immuno-Oncology at The Angeles Clinic and Research Institute, shares insights and updates from ASCO 2024, with a special focus on melanoma, non-melanoma skin cancers, and ocular/uveal melanoma.

AIM at Melanoma raises awareness of preventive measures; provides support for patients, caregivers, and survivors; and funds critical research—all to end melanoma in our lifetime. AIM is dedicated to fighting the world's deadliest skin cancer, melanoma.

From immunotherapy to targeted therapies, there is hope for a brighter future for those affected by this disease. Stay tuned for more updates on these groundbreaking treatments as more research continues to be conducted.

If you or a loved one has been diagnosed with melanoma or any other type of skin cancer, it is important to work closely with your medical team to discuss all available treatment options and determine the best course of action. Remember, early detection and prompt treatment can significantly improve outcomes. Don't hesitate to reach out for support, whether it be from friends and family or professional counseling services.

Let's continue raising awareness about skin cancer prevention and treatment and working towards a world free of this disease. Together, we can make a difference and save lives. Thank you for your continued support. Stay safe and stay healthy.